Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) 是一种针对EGFR的全人糖工程 IgG1 单克隆抗体。Tomuzotuximab 具有抗癌作用。
| 生物活性 | Tomuzotuximab (Anti-HumanEGFRRecombinant Antibody) is a fully human glycoengineeredIgG1monoclonal antibody againstEGFR. Tomuzotuximab has anticancer effects[1]. |
体外研究
(In Vitro) | Tomuzotuximab has a fully human glycosylation pattern and is glyco-optimised at its Fc domain, while fully retaining the affinity, specificity, EGFR inhibition and induction of apoptosis of Cetuximab[1].
|
| CAS 号 | |
| 中文名称 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
